Want to see AIFF full AI Analyst Report?
Firefly Neuroscience (AIFF) Ratios
Firefly Neuroscience Ratios
AIFF's free cash flow for Q2 2026 was $-1.79M. For the 2026 fiscal year, AIFF's free cash flow was decreased by $-42.00K and operating cash flow was $-1.75M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.43 | 0.53 | 0.89 | 0.04 | 0.18 |
| Quick Ratio | 1.39 | 0.53 | 0.89 | 0.04 | 0.18 |
| Cash Ratio | 0.97 | 0.36 | 0.85 | 0.03 | 0.16 |
| Solvency Ratio | -6.94 | -2.09 | -1.03 | -1.68 | -1.00 |
| Operating Cash Flow Ratio | -2.91 | -1.24 | -0.86 | -1.29 | -0.96 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -8.87 | 0.00 | 0.00 | -2.14 |
| Net Current Asset Value | $ 1.19M | $ -2.35M | $ -277.00K | $ -2.16M | $ -3.26M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.15 | 0.00 | 0.00 | 1.88 |
| Debt-to-Equity Ratio | 0.00 | -1.85 | 0.00 | 0.00 | -0.59 |
| Debt-to-Capital Ratio | 0.00 | 2.18 | 0.00 | 0.00 | -1.46 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.37 | -12.27 | 24.23 | -0.06 | -0.32 |
| Debt Service Coverage Ratio | -122.96 | -13.53 | -143.61 | -5.58 | -1.98 |
| Interest Coverage Ratio | -54.12 | -133.04 | -171.00 | -5.80 | -34.47 |
| Debt to Market Cap | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.12 | 0.00 | 0.07 | 0.24 |
| Net Debt to EBITDA | 0.14 | 0.11 | 0.83 | 0.02 | -0.30 |
| Profitability Margins | |||||
| Gross Profit Margin | 56.48% | 37.96% | 100.00% | 0.00% | 100.00% |
| EBIT Margin | -1726.62% | -9619.44% | -518.88% | 0.00% | -13268.75% |
| EBITDA Margin | -1711.56% | -9557.41% | -518.88% | 0.00% | -11928.13% |
| Operating Profit Margin | -753.50% | -8500.00% | -618.07% | 0.00% | -14543.75% |
| Pretax Profit Margin | -1740.54% | -9683.33% | -522.49% | 0.00% | -13690.63% |
| Net Profit Margin | -1740.98% | -9685.19% | -522.69% | 0.00% | -13690.63% |
| Continuous Operations Profit Margin | -1740.98% | -9685.19% | -522.69% | 0.00% | -13690.63% |
| Net Income Per EBT | 100.03% | 100.02% | 100.04% | 100.00% | 100.00% |
| EBT Per EBIT | 230.99% | 113.92% | 84.54% | 113.82% | 94.13% |
| Return on Assets (ROA) | -189.77% | -227.34% | -98.56% | -2806.67% | -459.71% |
| Return on Equity (ROE) | -260.34% | 2789.33% | -2388.07% | 179.49% | 145.36% |
| Return on Capital Employed (ROCE) | -112.37% | 2448.00% | -2823.85% | 157.70% | 154.41% |
| Return on Invested Capital (ROIC) | -112.37% | -2877.74% | -2823.85% | 157.70% | 379.61% |
| Return on Tangible Assets | -447.69% | -236.60% | -115.43% | -2806.67% | -460.19% |
| Earnings Yield | -172.20% | -60.29% | -6.52% | -3.34% | -0.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.89 | 0.89 | 5.93 | 0.00 | 0.78 |
| Payables Turnover | 0.37 | 0.04 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 4.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 7.82 | 0.79 | 0.00 | 0.00 | 0.17 |
| Asset Turnover | 0.11 | 0.02 | 0.19 | 0.00 | 0.03 |
| Working Capital Turnover Ratio | -2.00 | -0.08 | -0.41 | 0.00 | -0.04 |
| Cash Conversion Cycle | -847.92 | -9484.20 | 61.57 | 0.00 | 467.66 |
| Days of Sales Outstanding | 62.01 | 408.94 | 61.57 | 0.00 | 467.66 |
| Days of Inventory Outstanding | 79.32 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 989.25 | 9893.13 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 141.32 | 408.94 | 61.57 | 0.00 | 467.66 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.62 | -0.94 | -0.28 | -0.37 | -0.49 |
| Free Cash Flow Per Share | -0.63 | -1.00 | -0.33 | -0.37 | -0.49 |
| Dividend Paid and CapEx Coverage Ratio | -64.02 | -14.83 | -5.63 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -64.02 | -14.83 | -5.63 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | -8.87 | 0.00 | 0.00 | -2.14 |
| Operating Cash Flow to Sales Ratio | -7.18 | -56.99 | -4.36 | 0.00 | -119.38 |
| Free Cash Flow Yield | -72.08% | -37.87% | -6.41% | -2.55% | -0.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.47 | -1.66 | -15.33 | -29.91 | -266.77 |
| Price-to-Sales (P/S) Ratio | 10.11 | 160.64 | 80.12 | 0.00 | 36522.88 |
| Price-to-Book (P/B) Ratio | 1.51 | -46.26 | 366.07 | -53.69 | -387.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.39 | -2.64 | -15.60 | -39.19 | -305.95 |
| Price-to-Operating Cash Flow Ratio | -1.41 | -2.82 | -18.37 | -39.19 | -305.95 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | -0.00 | 0.49 | 2.09 | 0.23 |
| Enterprise Value Multiple | -0.45 | -1.57 | -14.61 | -35.39 | -306.49 |
| Enterprise Value | 8.80M | 16.23M | 37.76M | 113.27M | 1.17B |
| EV to EBITDA | -0.45 | -1.57 | -14.61 | -35.39 | -306.49 |
| EV to Sales | 7.70 | 150.30 | 75.82 | 0.00 | 36558.35 |
| EV to Free Cash Flow | -1.06 | -2.47 | -14.76 | -39.17 | -306.25 |
| EV to Operating Cash Flow | -1.07 | -2.64 | -17.38 | -39.17 | -306.25 |
| Tangible Book Value Per Share | 0.12 | -0.08 | -0.04 | -0.27 | -0.38 |
| Shareholders’ Equity Per Share | 0.58 | -0.06 | 0.01 | -0.27 | -0.38 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.09 | 0.02 | 0.06 | 0.00 | 0.00 |
| Net Income Per Share | -1.51 | -1.60 | -0.33 | -0.48 | -0.56 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.01 | 1.01 | 1.18 | 1.03 |
| Research & Development to Revenue | 1.30 | 18.09 | 1.49 | 0.00 | 91.44 |
| SG&A to Revenue | 6.80 | 67.91 | 4.41 | 0.00 | 51.91 |
| Stock-Based Compensation to Revenue | 0.68 | 25.19 | 0.59 | 0.00 | 19.00 |
| Income Quality | 0.41 | 0.59 | 0.83 | 0.76 | 0.87 |
Currency in USD